Psychedelic Medicine
Association
Psychedelic
Medicine
Association
Psychedelic Medicine
Association
Psychedelic
Medicine
Association
President, Psychedelic Medicine Association
Founder and CEO, Odyssey
Gabe Charalambides is the founder of Odyssey, one of the first legal psilocybin retreat centers in the United States. A former aerospace engineer, Gabe discovered meditation and Buddhist philosophy more than 15 years ago, and early psychedelic experiences sparked a lasting fascination with psychological well-being. After a decade in the aerospace world, he decided to focus on mental health and, in 2023, launched Odyssey to bring science-based, transformative psilocybin experiences to others. Gabe holds an M.S. in Aeronautics & Astronautics and an MBA from Stanford University.
Colorado Director, Healing Advocacy Fund
Tasia Poinsatte serves as the Colorado Director of the Healing Advocacy Fund, a nonprofit that works to protect and expand safe, affordable state-regulated access to psychedelic healing for all who need it. In Colorado, Tasia has organized expert stakeholder input to inform a responsible and accessible state-regulated program for psilocybin therapies, advocating for an integrated program with direct participation by licensed clinicians to support safety and efficacy. HAF is actively engaged in educating Colorado policymakers, providers and the public regarding the risks and benefits of psychedelic therapies and opportunities within Colorado’s legal framework. Prior to joining HAF, Tasia conducted research and advised strategy on campaigns and causes in the US and internationally, including passage of Colorado’s Natural Medicine Health Act in 2022.
Licensed Psilocybin Facilitator, Marriage & Family Therapist Associate, Trainer Faculty for Fluence
Kayli Howard has a MA in Clinical Psychology from Antioch University, where she trained as a Marriage and Family Therapist. In 2023 she received certification in Psilocybin-Assisted Therapy through Fluence. She is one of Oregon’s first licensed psilocybin facilitators. Since receiving licensure she has guided nearly 150 legal psychedelic journeys and was awarded the “Clients' Choice” in Althea's Psilocybin Outcome Awards. She trains upcoming psychedelic facilitators as a faculty member of Fluence’s Colorado Natural Medicine program.
Chief Medical Officer at Novamind/Co-founder at Cedar Psychiatry
Dr. Reid Robison is a board-certified psychiatrist and Chief Medical Officer at Novamind. Reid is co-founder at Cedar Psychiatry and serves as Medical Director of Center for Change, a top Eating Disorder program. He is currently the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad.
As Oregon continues to expand its regulated psilocybin services program—and Colorado’s own program begins offering facilitated sessions—clinicians across the country are being asked to engage with this rapidly evolving field. With licensed service centers now operating in both states, legal psilocybin therapy is no longer theoretical.
If you're a clinician or therapist, you may soon encounter patients who are considering, or have already undergone, psilocybin experiences through these state-regulated models. Would you know how to assess whether it's safe for them? Would you understand what the therapeutic process actually looks like?
While psilocybin remains federally illegal, Oregon and Colorado are actively shaping the future of psychedelic-assisted therapy, and clinicians will be on the front lines of supporting patients navigating this new terrain.
In this webinar, experts will break down:
Whether you're practicing in a state with legal psilocybin services or preparing for future policy changes, this conversation will help you stay informed and ready to support your patients safely and effectively.
As always, there will be ample time for audience Q&A, so you’ll get to interact with the panelists directly!
So please join us for this live panel discussion on Tuesday, July 22nd at 5 pm Pacific, 8 pm Eastern. This is exclusively for members of the Psychedelic Medicine Association, so if you have not yet registered, please do so here. And for members, please register for the panel here. A link to the recording will be available afterward if you cannot make it to the live event.
You can find the Psychedelic Medicine Association on Twitter, LinkedIn, and on Facebook.